SPARC is an extracellular matrix protein that is present at high levels in many metastatic cancers 44
Abstract 21
Overexpression of SPARC, a collagen-binding glycoprotein, is strongly associated with tumor 22 invasion through extracellular matrix in many aggressive cancers. SPARC regulates numerous 23 cellular processes including integrin-mediated cell adhesion, cell signaling pathways, and 24 extracellular matrix assembly; however, the mechanism by which SPARC promotes cell invasion 25 in vivo remains unclear. A main obstacle in understanding SPARC function has been the 26 difficulty of visualizing and experimentally examining the dynamic interactions between 27 invasive cells, extracellular matrix and SPARC in native tissue environments. Using the model 28 of anchor cell invasion through the basement membrane (BM) extracellular matrix in 29
Caenorhabditis elegans, we find that SPARC overexpression is highly pro-invasive and rescues 30 BM transmigration in mutants with defects in diverse aspects of invasion, including cell polarity, 31 invadopodia formation, and matrix metalloproteinase expression. By examining BM assembly, 32 we find that overexpression of SPARC specifically decreases levels of BM type IV collagen, a 33 crucial structural BM component. Reduction of type IV collagen mimicked SPARC 34 overexpression and was sufficient to promote invasion. Tissue-specific overexpression and 35 photobleaching experiments revealed that SPARC acts extracellularly to inhibit collagen 36 incorporation into BM. By reducing endogenous SPARC, we also found that SPARC functions 37 normally to traffic collagen from its site of synthesis to tissues that do not express collagen. We 38 propose that a surplus of SPARC disrupts extracellular collagen trafficking and reduces BM 39 collagen incorporation, thus weakening the BM barrier and dramatically enhancing its ability to 40 be breached by invasive cells. 41 42 Introduction glioblastoma, pancreatic ductal adenocarcinoma, clear-cell renal cell carcinoma, melanoma, and 84 prostate carcinoma (reviewed in (18, 19) ). Supporting a direct role for SPARC in promoting 85 metastasis, murine breast and pancreatic cancer metastasis models have shown that elevated 86 SPARC levels increase metastatic potential (20, 21) . Furthermore, increased SPARC or 87 exogenous addition of SPARC enhances invasion in in vitro assays (20, (22) (23) (24) (25) (26) (27) . Although a 88 crucial factor in promoting cancer metastasis and invasion, the mechanism(s) by which increased 89 SPARC expression enhances invasive ability in vivo is not understood (18, 19) . 90 SPARC has been implicated in numerous cellular processes, including growth factor 91 signaling, cell-ECM interactions, and ECM assembly (18) . Several of these putative SPARC 92 functions may promote cell invasive behavior by facilitating BM breach, including a positive 93 correlation between SPARC and matrix metalloproteinase (MMP) expression (28) (29) (30) (31) or integrin 94 signaling (32) (33) (34) (35) (36) . SPARC also plays a conserved role in regulating assembly of BM type IV 95 collagen and interstitial fibrillar collagen (37-41); and may affect ECM by modulating collagen 96 processing (32, 42) or through a direct chaperone-like interaction with type IV collagen (43) (44) (45) . 97
In addition, SPARC has been proposed to regulate ECM disassembly (46) . As the majority of 98 mechanistic studies examining SPARC function during cancer metastasis have been conducted 99 using in vitro cell culture models, it is not clear which, if any, of these mechanisms are relevant 100 to SPARCs pro-invasive function in vivo. 101
Anchor cell (AC) invasion during C. elegans larval development is an experimentally 102 tractable model to mechanistically examine BM remodeling, BM dynamics, and BM 103 transmigration in vivo (3, (47) (48) (49) . AC invasion through the juxtaposed gonadal and ventral BMs 104 is highly stereotyped and occurs in tight coordination with the divisions of the underlying vulval 105 precursor cell (VPC) P6.p. The AC breaches the BM using F-actin rich invadopodial protrusions 106 after P6.p has divided once (P6.p two-cell stage, Fig 1A) , and completely removes the 107 underlying BM after a second round of VPC divisions (P6.p four-cell stage; ~ 90 minute time 108 period). Following invasion, the VPCs divide again and invaginate (P6.p eight-cell stage). 109
Previous research has identified several pathways that promote distinct aspects of AC invasion 110 (summarized in Fig 1B) . The conserved Fos family transcription factor FOS-1A regulates the 111 expression of genes, including the matrix metalloproteinase zmp-1, that promote BM breaching 112 (49, 50) . Integrin signaling (ina-1 and pat-3 heterodimer) stabilizes F-actin regulators at the AC-113 BM interface that mediate the formation of invadopodia-small, dynamic cellular protrusions 114 that breach the BM (49). Netrin signaling (unc-6/netrin and the receptor unc-40/DCC) is 115 activated at the site of BM breach and facilitates the generation of a large invasive protrusion that 116 rapidly clears an opening through the BM (51, 52). In addition, AC invasion is stimulated by an 117 unidentified diffusible cue from the underlying vulval cells that activates the Rho GTPase CDC-118 42, which induces robust invadopodia formation (53-56). Loss of these pathways results in 119 highly penetrant blocks or slowing of AC invasion. Importantly, Fos transcription factors, 120 integrin, netrin, and Cdc42 are all strongly implicated as potent promoters of metastasis and 121 tumor cell invasion (57-62), suggesting that the mechanisms that control AC invasion are 122 conserved and co-opted by tumors (63). Whether SPARC overexpression promotes invasive 123 ability in the AC, similar to its effect on tumor cells in metastatic cancer, is not known. 124
In this study we use a combination of genetics, transgenics, and in vivo live cell imaging 125 to determine if SPARC overexpression promotes AC invasion. We show that SPARC 126 overexpression restores AC invasion when fos-1a, integrin, netrin signaling, or the vulval cue are 127 compromised, indicating SPARC overexpression is strongly pro-invasive. We find that 128 SPARC's pro-invasive function is dependent on its collagen binding ability and that SPARC 129 and that overexpression of SPARC perturbs its normal trafficking function, thus decreasing BM 138 collagen deposition, weakening these barriers and promoting BM transmigration by invasive 139
cells. 140 141

Results
142
SPARC overexpression promotes AC invasion in multiple mutant backgrounds 143
SPARC overexpression is strongly associated with tumor metastasis in many different 144 cancers and promotes cancer cell invasion (18, 19, 64) . We thus wanted to determine if SPARC 145 overexpression might also promote AC invasion in C. elegans. We created integrated multi-copy 146 transgenes using the endogenous SPARC promoter to drive SPARC (the gene ost-1 in C. 147 elegans) mRNA and protein production at a two-to-five fold increase over normal levels (S1 148 Fig) . As the timing of AC invasion is precisely regulated by multiple extracellular cues and 149 intrinsic factors (47), an increase in SPARC is unlikely to accelerate AC invasion. Consistent 150 with this prediction, ACs in worms overexpressing SPARC completed invasion at the normal 151 time during the P6.p four-cell stage (see Fig 1A; n=27/27 P6.p four-cell stage, 56/56 P6.p eight-152 cell stage animals). Thus, overexpression of SPARC does not appear to alter the endogenous 153 invasion program. 154
We next asked if SPARC overexpression promotes invasion in mutant backgrounds 155 where invasion is inhibited or slowed by loss of specific pathways. We first examined animals 156 with a null mutation in the transcription factor fos-1a (fos-1(ar105)). FOS-1A promotes BM 157 breaching, controlling expression of matrix metalloproteases that degrade ECM (1, 65) and loss 158 of fos-1a results in a highly penetrant block or delay in AC invasion (50). While ACs in fos-159 1(ar105) mutant worms successfully breached the BM in only 23% of animals by the P6.p eight-160 cell stage (n=23/100 animals, Fig 1C and act independently of this pathway. To distinguish between these possibilities, we overexpressed 165 SPARC in animals harboring mutations in other pathways regulating AC invasion -integrin, 166 netrin signaling, and the vulval cue (the latter absent when the vulval cells are not specified in 167 lin-3(n1059)/lin-3(n378) worms; Fig 1B (51-53) ). Strikingly, in all genetic backgrounds, SPARC 168 overexpression significantly increased the frequency of AC invasion ( Fig 1D) . These studies 169 indicate that SPARC overexpression is broadly pro-invasive and can compensate for the loss of 170 multiple distinct pathways that promote AC invasion. 171 172
The pro-invasive function of SPARC is dependent on collagen binding 173
We next sought to elucidate the mechanism by which SPARC enhances invasion. 174
Previous work has indicated that SPARC can alter a number of genes and pathways that could 175 promote invasion in vivo, including MMP expression and activation (28-31), as well as integrin 176 signaling (32) (33) (34) (35) (36) . SPARC overexpression promoted invasion in animals with defects in 177 invadopodia assembly (vulval cue/integrin/cdc-42), invasive protrusion formation (netrin 178 pathway), and MMP expression (fos-1a), suggesting that SPARC has a broad and possibly 179 distinct function in augmenting the ability of the AC to invade. Previous studies have also 180 implicated SPARC as an important regulator of type IV collagen deposition in BM (12, 39, 41) . 181
As type IV collagen is a major structural barrier that cells must overcome to breach BM (1), we 182 hypothesized that SPARC-mediated alterations of BM collagen might allow even weakly 183 invasive ACs to transmigrate the BM barrier. We thus examined the relationship between 184 SPARC and type IV collagen during AC invasion. In C. elegans overexpressed SPARC::GFP 185 and endogenous SPARC are produced primarily in the body wall and vulval muscles, and 186 localize to the BMs surrounding all other tissues (Fig 2A and B, (66) ). Type IV collagen also 187 localizes to the BM and is expressed primarily in the body wall muscles, with the neuronal ring 188 ganglion, spermatheca, uterine muscles, vulval muscles, and the distal tip cell of the somatic 189 gonad also contributing collagen during specific larval stages (Fig 2A and B; (67)). Previous in 190 vitro studies have identified a collagen-binding pocket in SPARC that is highly conserved from 191 C. elegans to humans (37, 43, 45, 68, 69) . To determine if a direct interaction between SPARC 192 and collagen is required for SPARC to promote invasion, we created two point mutations, R152L 193 and Q159A, in the collagen-binding pocket of SPARC. These point mutations abrogate collagen 194 binding without altering SPARC conformation (43). In addition, these mutations do not disrupt 195 the follistatin domain (residues 52-75), which is sufficient for SPARC to directly bind and 196 activate integrin (70). We drove wild type SPARC and the form of SPARC unable to bind 197 collagen (SPARC R152L,Q159A ) under the control of a heat shock promoter in the fos-1(ar105) 198 mutant background. We found that overexpressed SPARC R152L,Q159A was localized to the BM at 199 levels sufficient to promote invasion (S2 Fig) ; however, this mutant form of SPARC was not 200 pro-invasive ( Fig 2C) . In contrast, wild type SPARC driven by the heat shock promoter almost 201 fully rescued AC invasion in the fos-1 mutant background ( Fig 2C) . These results indicate that a 202 direct interaction between SPARC and collagen is essential for SPARC's ability to promote AC 203 invasion. 204
205
SPARC overexpression decreases levels of type IV collagen in the BM 206
We next wanted to determine how SPARC's interaction with type IV collagen influences 207 collagen within the BM. In C. elegans type IV collagen monomers are composed of two α1 208 chains encoded by emb-9, and one α2 chain encoded by let-2 (71, 72). We examined if 209 overexpression of SPARC alters the localization of a functional type IV collagen reporter, EMB-210 9::mCherry (henceforth referred to as collagen::mCherry (73)). We observed that overexpressing 211 SPARC decreased BM collagen::mCherry levels by approximately 50% (Fig 3A) . In contrast, 212 SPARC overexpression did not significantly alter the levels of the other key BM scaffolding 213 component laminin, suggesting overexpressed SPARC specifically regulates type IV collagen 214 levels in the BM ( Fig 3A) . 215 216
Reduction of type IV collagen can account for SPARC's pro-invasive activity 217
Given the key structural role of type IV collagen in BM, our observations suggested that 218 overexpressed SPARC might promote invasion by reducing the levels of type IV collagen. To 219 determine if reduction of collagen levels in the BM alone is sufficient to enhance AC invasion, 220 we used RNAi targeting emb-9 to decrease type IV collagen levels in the BM (an average of 221 63% reduction in collagen::mCherry fluorescence, mimicking overexpression of SPARC, Fig  222   3A ). Similar to SPARC overexpression, decreasing the levels of type IV collagen significantly 223 restored AC invasion in multiple mutant backgrounds where invasion is delayed or inhibited ( Fig  224   3B ). Together, these results suggest that SPARC promotes AC invasion by decreasing the level 225 of type IV collagen in the BM. Fig (74) ). Although 233 colocalized during vesicle trafficking, previous studies have largely indicated that SPARC does 234 not regulate intracellular trafficking of type IV collagen (12, 41). We thus sought to determine if 235 overexpression of extracellular SPARC was sufficient to decrease BM type IV collagen. To test 236 this, we separated the site of SPARC overexpression from the site of type IV collagen 237 production. We took advantage of the neurons, which constitute a large population of cells in C. 238 elegans. Neurons in C. elegans have not been reported to express SPARC but do express other 239 ECM proteins, indicating that they are capable of secreting matrix proteins into the extracellular 240 space (75). We drove SPARC using the pan-neuronal rab-3 promoter ((76); rab-241 3>SPARC::GFP). Strikingly, we found that neuronally expressed SPARC decreased the amount 242 of type IV collagen in the BM and promoted AC invasion (Fig 4) . Notably, these strong effects 243 were observed even though neuron-generated overexpression of SPARC::GFP resulted in less 244 additional BM-localized SPARC than overexpressed SPARC::GFP driven by the endogenous 245 SPARC promoter (S2 Fig) . We conclude that overexpressed SPARC has an extracellular role in 246 reducing type IV collagen levels in the BM. 247
248
SPARC overexpression slows collagen incorporation into the BM 249
The lower levels of BM collagen in animals overexpressing SPARC suggested that 250 extracellular SPARC might regulate the rate of collagen turnover (addition and/or removal) in 251 the BM. To determine if SPARC overexpression alters collagen turnover, we examined 252 fluorescence recovery after photobleaching (FRAP) of collagen::mCherry in the BM. We 253 photobleached collagen::mCherry in the BM surrounding half of the uterine tissue and measured 254 FRAP, using the unbleached half of the uterine tissue as a control to estimate total BM collagen 255 levels throughout the experiment. Bleaching this large region rendered the extremely limited 256 diffusion of BM localized type IV collagen negligible (Ihara et al., 2011) . In wild type worms, 257 44±4% of the total collagen in the BM was replaced with fluorescent collagen two hours after 258 photobleaching. In contrast, when SPARC was overexpressed under its endogenous promoter, 259 only 25±3% of collagen recovered two hours after photobleaching (p<0.005 compared to wild 260 type; Fig 5) . These observations suggest that excessive extracellular SPARC decreases collagen 261 addition to the BM. In sum, these results indicate that SPARC overexpression decreases type IV 262 collagen incorporation into the BM, which weakens this barrier to cell invasion. 263 264
Reduction of SPARC perturbs collagen trafficking during development 265
Our studies above suggested that increased SPARC expression interferes extracellularly 266 with type IV collagen incorporation into the BM. Recent work in Drosophila has suggested that 267 SPARC normally functions extracellularly to promote type IV collagen solubility after secretion 268 (41). To investigate the normal role of SPARC in regulating type IV collagen assembly in C. 269 elegans, we examined the type IV collagen-rich BM surrounding the pharynx, the muscular 270 foregut of the worm that grinds food and transports it to the intestines (77, 78). The pharynx does 271 not express type IV collagen, suggesting that collagen is recruited to the pharyngeal BM from a 272 distant collagen production site, likely the body wall muscle (67). We reasoned that if SPARC 273 acts to promote extracellular collagen solubility, then the pharyngeal BM would be particularly 274 sensitive to reduction of SPARC function as it is localized at a distance from the site of type IV 275 collagen synthesis (unlike the gonadal BM which can receive collagen from the nearby distal tip 276 cell and sex muscles (67)). 277
Consistent with previous reports, we found that worms harboring putative null alleles in 278 the SPARC locus ost-1(tm966) and ost-1(tm6331)) are embryonic and early larval lethal 279 precluding analysis of SPARC function during later larval development (S4 Fig) (66) . Thus, we 280 reduced late larval SPARC levels by RNAi-mediated targeting (an average of 97% reduction, see 281 Methods). SPARC reduction led to a dramatic decrease in type IV collagen levels in the 282 pharyngeal BM (approximately 60% reduction in collagen::mCherry fluorescence compared to 283 wild type animals, Fig 6A) . This loss of collagen was frequently accompanied by severe 284 morphological defects in the pharyngeal bulbs (n=20/33 animals, Fig 6A) , indicating that the 285 structural integrity of the pharynx had been compromised. Levels of the BM component laminin 286 were not significantly affected by SPARC knockdown (Fig 6A) , suggesting that SPARC is 287 specifically required for type IV collagen incorporation into the BM. Notably, we also observed 288 an approximately two-fold increase in accumulation of collagen at the surface of the body wall 289 muscle (where type IV collagen is expressed and secreted) after reduction of SPARC ( Fig 6B) . 290
Together, these results suggest that SPARC is required to transport type IV collagen from the 291 surface of the body wall muscle to the pharyngeal BM during development. 292
Interestingly, we found that reduction of SPARC did not alter the levels of collagen 293 surrounding the gonadal BM at the time of AC invasion ( Fig 6C) . As the distal tip cell of the 294 somatic gonad and vulval sex muscles both produce type IV collagen and are in direct contact 295 with the gonadal BM, SPARC may not be required to traffic extracellular collagen to the gonadal 296 BM or very low levels of SPARC might be sufficient for transport. Consistent with unaltered 297 collagen levels in the BM, SPARC reduction did not change the frequency of AC invasion in the 298 unc-40 (netrin receptor DCC) mutant background ( Fig 6D) . In addition, reduction of SPARC did 299 not affect the timing or frequency of invasion in wild type animals (n=49/50 animals invaded by 300 the P6.p four-cell stage and 50/50 by the P6.p eight-cell stage). Together, these results indicate 301 that SPARC has an important role in regulating the transport of type IV collagen to tissues 302 located at a distance from sources of collagen production. Furthermore, our results suggest that 303 overexpression of SPARC disrupts its normal extracellular function in collagen trafficking, 304 leading to a reduction in collagen BM deposition. 305 306 Discussion 307
The matricellular protein SPARC has been implicated in regulating many molecular 308 functions important in tissue growth, morphogenesis, and homeostasis; including cell-matrix 309 adhesion, growth factor activity, and ECM dynamics (18, 79) . The diverse functions of SPARC, 310 compounded by the challenge of studying cell invasion and BM dynamics in vivo, have made it 311 difficult to understand how overexpression of SPARC in metastatic cancers promotes cell 312 invasion and tumor spread (15, 18) . Using AC invasion in C. elegans as an in vivo model to 313 examine the role of SPARC in regulating BM transmigration, our genetic, site of action and live 314
imaging studies indicate that SPARC overexpression functions permissively to facilitate cell 315 invasion by inhibiting type IV collagen deposition in the BM, thus weakening BM barrier 316 properties (summarized in Fig 7) . 317
While overexpression of SPARC did not alter the timing of the normal AC invasion 318 program, we found that it dramatically restored AC invasion in numerous genetic backgrounds 319
where AC invasion is delayed or completely blocked. Furthermore, type IV collagen imaging 320 and FRAP analysis showed that SPARC overexpression led to a significant decrease in collagen 321 deposition in the BM, and that RNAi-mediated reduction in BM collagen mimicked the pro-322 invasive activity of SPARC. These data provide compelling evidence that SPARC 323 overexpression promotes invasion by reducing BM type IV collagen levels. Changes in the 324 structure and composition of ECMs can signal to invasive cells through integrin clustering or 325 biomechanical pathways (4, 5); thus altering the properties of the BM may lead to an increase in 326 the pro-invasive signals the AC receives from its environment. Alternatively, as the type IV 327 collagen lattice is highly cross-linked and endows BM with its mechanical strength and barrier 328 properties (4, 5), decreasing the levels of type IV collagen may weaken the BM, allowing this 329 barrier to be more easily breached by invading cells. As we found that SPARC overexpression 330 broadly promotes invasion after the reduction or absence of all previously identified signaling 331 pathways regulating AC invasion (netrin, integrin, Fos and vulval cue pathways), our data 332 support the idea that SPARC overexpression does not augment one of these previously identified 333 pathways. Instead, we hypothesize that by limiting type IV collagen addition to BM, SPARC 334 weakens the BM and allows it to be transmigrated more easily by ACs that have limited invasive 335 capacity. Consistent with this idea, decreasing type IV collagen levels in BM has also been 336 proposed to facilitate neutrophil extravasation through the venule BM (3, 80, 81) . Furthermore, 337 studies in colon cancer have suggested that reduction in type IV collagen expression via 338 hypermethylation of collagen encoding genes may create a weaker BM that is more permissive 339 to invasion (82). 340
The co-emergence of SPARC with collagen in basal metazoans and the presence of 341 the highly conserved collagen-binding site in SPARC proteins (37, 83) suggest that SPARC 342 and collagen have an ancient functional relationship. Previous work on Drosophila larvae 343 has shown that in the absence of SPARC, collagen accumulates around the fat body (the site 344 of collagen synthesis) and is absent from the BM of the ventral nerve cord, which does not 345 express type IV collagen (12, 40, 41) . We observed a similar accumulation of collagen at the 346 surface of collagen-expressing body wall muscle cells upon reduction of SPARC in C. 347 elegans, and a reduction of collagen within the pharyngeal BM, which does not express type 348 IV collagen. These observations are consistent with the idea that SPARC acts to promote 349 type IV collagen solubility, allowing it to be distributed from sites of secretion to the BM of 350 distant tissues lacking its expression (Fig 7) . Binding of SPARC to collagen might promote 351 collagen solubility by preventing collagen from interacting with cell surface receptors and 352 existing BM, or by inhibiting collagen polymerization (39, 41) . In organs such as the somatic 353 gonad that neighbor sites of type IV collagen synthesis, SPARC might not be required to 354 move extracellular collagen or may play a more limited function in collagen trafficking. We 355 suspect that when SPARC levels are high, collagen remains soluble and fails to incorporate 356 as efficiently into BMs. The excess soluble collagen in the extracellular fluid is likely 357 removed by coelomocytes, macrophage-like scavenger cells that endocytose numerous 358 molecules in the body cavity fluid (84). SPARC may play a similar role in promoting 359 collagen I solubility as cell culture studies have shown that addition of exogenous SPARC 360 results in collagen I removal from a pre-assembled ECM (46). Together, our studies strongly 361 support the emerging notion that SPARC acts as an extracellular type IV collagen chaperone 362 (39, 41) whose levels play a crucial role in mediating collagen transport and deposition in 363
ECMs. 364
Although previous studies have suggested that SPARC may either positively or 365 negatively regulate laminin (40, 41, 85) , we find that SPARC overexpression did not affect 366 laminin deposition. This is consistent with previous findings during Drosophila development 367
also showing that SPARC affects collagen but not laminin deposition (12, 86). As the structure 368 and composition of BMs vary between tissues, the differing affect of SPARC on laminin may 369 reflect variances in the structure and composition of BMs, or may be an indirect affect of altering 370 collagen. Previous studies have also shown that SPARC interacts with collagen intracellularly to 371 inhibit collagen deposition in the BM of Drosophila egg chambers, thus SPARC overexpression 372 may alter collagen secretion (86). Our studies also showed that SPARC and collagen colocalized 373 in the bodywall muscle, potentially in the ER, however, we found that extracellular SPARC was 374 sufficient to alter collagen levels at the BM and promote invasion. While we cannot rule out the 375 possibility that SPARC overexpression alters collagen secretion, the ability of extracellular 376 SPARC (rab-3>SPARC) to recapitulate SPARC's regulation of type IV collagen and invasion 377 offers clear evidence that SPARC functions in the extracellular milieu to regulate collagen 378 deposition in BM. 379
Suggesting an important and context-dependent relationship with cancer, both increased 380 and decreased SPARC levels are associated with tumorigenesis (18, 87) . A decrease in SPARC 381 expression has been observed in numerous cancers including acute myeloid leukemia, multiple 382 forms of lung cancer, pancreatic ductal adenocarcinoma, and ovarian carcinoma (88) (89) (90) (91) (92) . 383
Adding exogenous SPARC to cell lines derived from these cancers inhibits cancer cell growth, 384
suggesting that a loss of SPARC promotes tumorigenesis by facilitating cell proliferation (90, 385 92-94) . Overexpression of SPARC is also associated with many cancers and high expression in 386 the cancer cells often increases metastatic potential (26, 31, 64) . Interestingly, in a subset of 387 epithelial cancers increased SPARC expression is confined to epithelial cells surrounding the 388 malignant cells (88, 89, 92, (95) (96) (97) (98) (99) . Our observations indicating that extracellular SPARC 389 reduces type IV collagen deposition suggests that increased SPARC expression from any nearby 390 tissue would likely reduce BM type IV collagen levels of the growing tumor and tumor 391 vasculature, making these tissues more readily traversed by malignant cells. We observed that a 392 relatively small increase in SPARC expression enhances AC invasion, suggesting that SPARC 393 expression may not need to be dramatically altered to promote metastasis. Given that our data 394 suggest that excessive SPARC acts to weaken the BM barrier, SPARC overexpression alone may 395 not be sufficient to endow a cell with metastatic capabilities, but may instead facilitate BM 396 breach for a cell that already has a basal level of invasive ability. Supporting this idea, breast 397 cancer lung metastases overexpressing SPARC require SPARC to promote invasion, but 398 overexpressing SPARC is not sufficient to drive metastasis (21). Together our data suggests that 399 SPARC expression must be tightly regulated to maintain ECM in a growing tissue, and that 400 therapeutic strategies buffering SPARC activity to within the optimal range for BM collagen 401 assembly may limit cell invasion during cancer metastasis. 402 403
Materials and Methods 404
C. elegans strain and culture information 405 C. elegans strains were cultured as previously described (100). The wild type strain was N2. In 406 the text and figures, we refer to linked DNA sequences that code for a single fusion protein using 407 a (::) annotation. For designating linkage to a promoter we use a (>) symbol. Alleles and 408 transgenes used in this study are as follows: syIs115(SPARC::GFP, unc-119(+)), 409 syIs113(SPARC::GFP, unc-119(+)), qyIs46 ), 410 qyIs202 (hsp>SPARC, ), qyIs240(hsp> SPARC R152L, Q159A ::GFP, qyEx480(Tram::mCherry), ), qyIs128 119(+)); LGI: unc-40(e271); LGII: rrf-3(pk1426); LGIII: unc-119(ed4), ina-1(gm39); LGIV: lin-414 3(n1059)/lin-3(n378), ost-1(tm966), ost-1(tm6331), qyIs10 ); LGV: fos-415 1(ar105); LGX: unc-6(ev400). 416 417 Microscopy, image acquisition, processing, and analysis 418 Images were acquired using a Hammamatsu EM-CCD camera, a spinning-disk confocal 419 microscope (CSU-10; Yokogawa Corporation of America) mounted on an AxioImager base 420 (Carl Zeiss) with 40× and 100× Plan Apochromat objectives (1.4 NA) and controlled by 421 µManager (101). Worms were photobleached on a Zeiss AxioImager A1 microscope with a 422 ×100 plan-apochromat objective by exposing a portion of the worms to 561 nm light for 2 423 minutes. Acquired images were processed to enhance brightness/contrast using ImageJ 1.40g 424 and Photoshop (CS6 Extended Adobe Systems, InC., San Jose, CA). Colocalization analysis was 425 performed on confocal z-using the "Coloc" module in IMARIS 7.4 (Bitplane, Inc., Saint Paul, 426 MN). Measurements of collagen::mCherry intensity at the BM were collected in ImageJ by 427 measuring the mean grey value of a 3 pixel width line drawn along the BM. An equivalent line 428 was drawn in an adjacent region of the worm to measure the background signal within the worm, 429 which was subtracted from the signal at the BM. 430 431
Analysis of AC invasion 432
AC invasion was scored at the P6.p four-cell and eight-cell stage as previously described (53). 433
Worms were staged by the divisions of the underlying P6.p vulval precursor cells. Animals were 434 scored as "complete invasion" if the BM was removed beneath the AC, "partial invasion" if the 435 BM was breached but not cleared beneath the AC, and "no invasion" if there was no BM breach. 436 437 Generation of SPARC overexpression lines 438 SPARC::GFP strains were made by injecting pOST8-X1/2 at 50-100 ng/µl with unc-119(+) into 439 unc-119(ed4) and then integrated. qyIs202 was made from a plasmid containing 440 hsp>SPARC::GFP, a gift from J. Schwarzbauer, created by fusing a 349 bp segment containing 441 the 1.48 intergenic region of hsp16-1/48 to the full ost-1 open reading and an additional 800 bp 442 3' flanking region. hsp> SPARC R152L,Q159A was made by inserting GFP between the first and 443 second exons of hsp>SPARC followed by site directed mutagenesis. rab-3>SPARC::GFP was 444 assembled by inserting the following regions into pBlueScript: rab-3 promoter (Kpn1, Apa1), 445 ost-1 exon1::GFP from pOST8-X1/2 (Apa1, EcoRV) and ost-1 exon 2-6 from cDNA (EcoRV, 446 Not1) . 447 448
Quantitative Real-Time PCR 449
Total RNA was prepared from mixed-staged populations (TriReagent, Sigma) and cDNA 450 synthesized using random primers (Invitrogen). An ost-1-specific primer set was designed as 451 follows: forward primer 5'GCATGGCTGACTGGCTCTT3', reverse primer 452 5'GTGGAGCTCACGTCTCTTCTT3', and FAM-labeled reporter with non-fluorescent 453 quencher spanning exon 4/exon 5 boundary 5'CCAGGTCATGAAGGAGCTT3'. act-4 (actin) 454 was selected as the normalization gene with FAM-labeled reporter with non-fluorescent 455 quencher 5'GGAGACGAAGCCCAGTCCAAGAGAG3' (Assay ID Ce02508047_s1, Applied 456
Biosystems, Foster City, CA). QPCR reactions used 1ng cDNA, Taqman Chemistry, and an ABI 457 prism 7000 (Applied Biosystems). Relative quantification of ost-1 mRNA levels were 458 standardized against act-4 levels and normalized to wild type N2. Data analysis was performed 459 using methods as described in the ABI Prism 7700 user bulletin #2. Each biological sample was 460 performed in duplicate and the PCR reaction was repeated in triplicate. 461
462
RNA interference 463
ost-1 cDNA fragments 67-660 bp and 129-727 bp were amplified by PCR from N2 cDNA, 464 cloned into the L4440 (pPD129.36) vector, and transformed into HT115 bacteria. Synchronized, 465 L1-arrested larvae were grown on regular OP50 bacteria at 20°C to the L4, after which they were 466 transferred to ost-1 RNAi plates. By performing an L4 RNAi plating, we were able to achieve 467 ~97% reduction of SPARC as measured by SPARC::GFP levels in L4 progeny (L4440 treated 468 animals fluorescence at BM= 6900±700 a.u.; ost-1 RNAi treated animals fluorescence at 469 BM=200±100 a.u.; ±SEM; n≥20 animals). SPARC reduction phenotypes were assessed in 470 L3/L4 progeny (at the time of AC invasion, for gonadal BM measurements) or young adult 471 progeny (for pharyngeal BM measurements). RNAi targeting emb-9 was acquired from the 472 Ahringer library (102), fed to synchronized L1 larvae, and phenotypes were assessed at the 473 L3/L4 at the time of invasion. The empty vector L4440 was used as a negative control in all 474
RNAi experiments. All RNAi vectors were sequenced to verify the correct insert. 475 476
Immunocytochemistry and western blot analysis 477
Worm strains were sectioned and immunostained as described and incubated with anti-LET-2 478 (NW68, 1:200)(67), anti-SPARC (1:400)(69) or anti-EPI-1 (1:500)(103). Worms were prepared 479 for western blot by washing synchronized L4 populations off NGM agar plates with OP50. 480
Worms were washed with M9 3-5 times and allowed to digest the bacteria remaining in their gut 481 for 30 minutes before flash freezing in liquid nitrogen. Worms were boiled in GLB buffer (2% 482 SDS, 10% glycerol, 50mM Tris-Ph 6.8, 5% β-mercaptoethanol) for 10 minutes, sonicated for 10 483 seconds, and boiled a final time immediately before loading onto a 4-15% MiniPROTEAN TGX 484 gel (BioRad, Hercules, CA). Blots were blocked with 5% dry milk in TBS-T and probed with Consortium. The location of the deletions tm6331 and tm966 is shown on top. Below, the 808 progeny from a timed egg lay of ost-1(tm6331)/+ (left) or ost-1(tm966)/+ (right). The progeny of 809 the egg lay were tracked for one week and their phenotypes were recorded. More than 25% of 810 the progeny of ost-1(tm6331) and ost-1(tm966) did not survive to adulthood (green), suggesting 811 that homozygotes of both mutant alleles are embryonic (dark red) or larval (light red) lethal. that maintains collagen solubility by inhibiting collagen polymerization and/or binding of 922 collagen to cell surface receptors. When SPARC levels are low, type IV collagen solubility in the 923 extracellular space is reduced resulting in an accumulation of collagen at the surface of collagen 924 expressing cells and a decrease in type IV collagen reaching distant sites of BM assembly. At 925 endogenous levels, SPARC helps transports collagen after secretion from sites of synthesis to 926 distant BMs. When SPARC is overexpressed, collagen solubility is increased, resulting in 927 reduced BM collagen incorporation. Previous studies have indicated that SPARC can bind 928 collagen in multiple locations, with two or three SPARC molecules per collagen being the most 929 common stoichiometry (44, 45) . 930
